Jian-Ping Xiao1, Gui-Xia Zhang1, Lei Chen2, Ben-Gui Sun3, Hong-Xu Zhang4, Li-Hong Chen5, Liang Yuan1, Li Hao1, De-Guang Wang6. 1. Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, 230601, Anhui, China. 2. Department of Nephrology, First People's Hospital of Hefei, 390 Huaihe Road, Hefei, Anhui, China. 3. Department of Nephrology, The Second People's Hospital of Hefei, 246 Heping Road, Hefei, Anhui, China. 4. Department of Nephrology, The Second People's Hospital of Anhui, 1686 Dangshan Road, Hefei, Anhui, China. 5. Department of Nephrology, The Armed Police Hospital of Anhui, 78 Shangfeng Road, Hefei, Anhui, China. 6. Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, 230601, Anhui, China. wangdeguang@ahmu.edu.cn.
Abstract
OBJECTIVE: To investigate the prevalence of restless legs syndrome (RLS) in maintenance hemodialysis (MHD) patients and its possible influencing factors. METHODS: MHD patients were consecutively enrolled from five hemodialysis centers in Hefei. Clinical, demographics, and laboratory data were recorded from December 2013 to March 2014. RLS diagnosis scale, Zung Self-Rating Depression Scale (SDS), Zung Self-Rating Anxiety Scale (SAS), Pittsburgh Sleep Quality Index (PSQI), and kidney disease and quality of life (KDQOLTM-36) were used for analysis. RESULTS: A total of 269 MHD patients (81 women, 188 men) were enrolled, among which 39 patients were diagnosed as RLS. The median duration of dialysis therapy was 33 months and the prevalence of RLS was 14.5%. Compared with RLS-negative patients, RLS-positive patients had lower hemoglobin level (98.67 ± 13.50 vs 106.34 ± 17.75, P = 0.011) and higher alkaline phosphatase concentration [131.0 (98.0, 226.0) vs 94.0 (69.8, 157.5), P = 0.001]. The multivariate logistic regression showed that high hemoglobin level (OR 0.975, 95% CI 0.956-0.995, P = 0.015) was a protective factor for RLS, while high alkaline phosphatase (OR 1.003, 95% CI 1.001-1.005, P = 0.018) was an independent risk factor for RLS. RLS patients had significantly higher PSQI scores (P < 0.001), reduced subjective sleep quality (P < 0.001), increased sleep latency (P < 0.007), shorter sleep duration (P < 0.001), lower sleep efficiency (P = 0.001), higher sleep disturbances (P < 0.001), and increased daytime dysfunction (P = 0.019). CONCLUSION: Our findings demonstrated that the prevalence of RLS was 14.5% in Hefei. High hemoglobin level was a protective factor for RLS, and high alkaline phosphatase was an independent risk factor. RLS affects many aspects of quality of life and sleep quality, which may contribute to the presence of depression and anxiety.
OBJECTIVE: To investigate the prevalence of restless legs syndrome (RLS) in maintenance hemodialysis (MHD) patients and its possible influencing factors. METHODS: MHD patients were consecutively enrolled from five hemodialysis centers in Hefei. Clinical, demographics, and laboratory data were recorded from December 2013 to March 2014. RLS diagnosis scale, Zung Self-Rating Depression Scale (SDS), Zung Self-Rating Anxiety Scale (SAS), Pittsburgh Sleep Quality Index (PSQI), and kidney disease and quality of life (KDQOLTM-36) were used for analysis. RESULTS: A total of 269 MHD patients (81 women, 188 men) were enrolled, among which 39 patients were diagnosed as RLS. The median duration of dialysis therapy was 33 months and the prevalence of RLS was 14.5%. Compared with RLS-negative patients, RLS-positive patients had lower hemoglobin level (98.67 ± 13.50 vs 106.34 ± 17.75, P = 0.011) and higher alkaline phosphatase concentration [131.0 (98.0, 226.0) vs 94.0 (69.8, 157.5), P = 0.001]. The multivariate logistic regression showed that high hemoglobin level (OR 0.975, 95% CI 0.956-0.995, P = 0.015) was a protective factor for RLS, while high alkaline phosphatase (OR 1.003, 95% CI 1.001-1.005, P = 0.018) was an independent risk factor for RLS. RLS patients had significantly higher PSQI scores (P < 0.001), reduced subjective sleep quality (P < 0.001), increased sleep latency (P < 0.007), shorter sleep duration (P < 0.001), lower sleep efficiency (P = 0.001), higher sleep disturbances (P < 0.001), and increased daytime dysfunction (P = 0.019). CONCLUSION: Our findings demonstrated that the prevalence of RLS was 14.5% in Hefei. High hemoglobin level was a protective factor for RLS, and high alkaline phosphatase was an independent risk factor. RLS affects many aspects of quality of life and sleep quality, which may contribute to the presence of depression and anxiety.
Entities:
Keywords:
Alkaline phosphatase; Hemoglobin; Maintenance hemodialysis; Prevalence; Restless legs syndrome
Authors: Adam Ogna; Valentina Forni Ogna; José Haba Rubio; Nadia Tobback; Dana Andries; Martin Preisig; Mehdi Tafti; Peter Vollenweider; Gerard Waeber; Pedro Marques-Vidal; Raphaël Heinzer Journal: Sleep Date: 2016-04-01 Impact factor: 5.849
Authors: I Stefanidis; A Vainas; E Dardiotis; C D Giannaki; P Gourli; D Papadopoulou; P Vakianis; E Patsidis; T Eleftheriadis; V Liakopoulos; S Pournaras; G K Sakkas; E Zintzaras; G M Hadjigeorgiou Journal: Sleep Med Date: 2013-10-10 Impact factor: 3.492
Authors: Antonio Alberto Lopes; Jennifer Bragg; Eric Young; David Goodkin; Donna Mapes; Christian Combe; Luis Piera; Philip Held; Brenda Gillespie; Friedrich K Port Journal: Kidney Int Date: 2002-07 Impact factor: 10.612